Status:
COMPLETED
A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following bunionectomy surgery.
Detailed Description
The duration of treatment is 5 days for rofecoxib and 1 day for diclofenac sodium.
Eligibility Criteria
Inclusion
- Bunion removal
Exclusion
- Any known allergies to the study design
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
251 Patients enrolled
Trial Details
Trial ID
NCT00092378
Start Date
September 1 2003
End Date
December 1 2003
Last Update
May 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.